To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Conditions
Rett Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Biomed Testing Facility # BIO-01-85012, Phoenix, Arizona, United States
Biomed Testing Facility # BIO-05-92093, La Jolla, California, United States
Biomed Testing Facility # BIO-04-90095, Los Angeles, California, United States
Biomed Testing Facility # BIO-03-95817, Sacramento, California, United States
Biomed Testing Facility # BIO-02-94104, San Francisco, California, United States
Biomed Testing Facility #BIO-06-80042, Aurora, Colorado, United States
Biomed Testing Facility #BIO-07-33606, Tampa, Florida, United States
Biomed Testing Facility #BIO-08-60612, Chicago, Illinois, United States
Maryland Locations Biomed Testing Facility #BIO-9-21205, Baltimore, Maryland, United States
Biomed Testing Facility #BIO-10-02115, Boston, Massachusetts, United States
Biomed Testing Facility #BIO-13-10467, The Bronx, New York, United States
Biomed Testing Facility #BIO-17-19104, Philadelphia, Pennsylvania, United States
Biomed Testing Facility #BIO-19-77030, Houston, Texas, United States
Biomed Testing Facility #BIO-20-98105, Seattle, Washington, United States
Biomed Research Unit-BIO-23-NSW 2050, Camperdown, New South Wales, Australia
Biomed Research Unit-BIO-24-NSW-4101, South Brisbane, Queensland, Australia
Biomed Research Unit-BIO-21-VIC-3084, Heidelberg West, Victoria, Australia
Biomed Research Unit- BIO-22-VIC 3010, Parkville, Victoria, Australia
Study leads
Lloyd L Tran, PhD
Study Director
Biomed Industries, Inc.
David Nguyen, PhD
Study Director
Biomed Industries, Inc.
Zung V Tran, PhD
Study Director
Biomed Industries, Inc.